| pubmed-article:3469171 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3469171 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:3469171 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:3469171 | lifeskim:mentions | umls-concept:C0020789 | lld:lifeskim |
| pubmed-article:3469171 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:3469171 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3469171 | pubmed:dateCreated | 1987-4-22 | lld:pubmed |
| pubmed-article:3469171 | pubmed:abstractText | Eighteen patients with non-small cell lung cancer were entered into a phase II protocol of oral 4-demethoxydaunorubicin. All were evaluable for toxicity and 17 for response. The major toxicity was hematologic with eight patients developing an ECOG grade 3 or 4 toxicity. There were no responses to the treatment. | lld:pubmed |
| pubmed-article:3469171 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3469171 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3469171 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3469171 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3469171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3469171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3469171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3469171 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3469171 | pubmed:issn | 0167-6997 | lld:pubmed |
| pubmed-article:3469171 | pubmed:author | pubmed-author:GreenM DMD | lld:pubmed |
| pubmed-article:3469171 | pubmed:author | pubmed-author:MuggiaF MFM | lld:pubmed |
| pubmed-article:3469171 | pubmed:author | pubmed-author:BlumR HRH | lld:pubmed |
| pubmed-article:3469171 | pubmed:author | pubmed-author:SpeyerJ LJL | lld:pubmed |
| pubmed-article:3469171 | pubmed:author | pubmed-author:WernzJ CJC | lld:pubmed |
| pubmed-article:3469171 | pubmed:author | pubmed-author:HochsterH SHS | lld:pubmed |
| pubmed-article:3469171 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3469171 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:3469171 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3469171 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3469171 | pubmed:pagination | 275-8 | lld:pubmed |
| pubmed-article:3469171 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:meshHeading | pubmed-meshheading:3469171-... | lld:pubmed |
| pubmed-article:3469171 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3469171 | pubmed:articleTitle | Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial. | lld:pubmed |
| pubmed-article:3469171 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3469171 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3469171 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
